Journal of Peking University (Health Sciences) ›› 2021, Vol. 53 ›› Issue (6): 1183-1187. doi: 10.19723/j.issn.1671-167X.2021.06.029

Previous Articles     Next Articles

Multicentric reticulohistiocytosis: A case report

ZHAI Li1,QIU Nan1,SONG Hui2,()   

  1. 1. Department of Rheumatology and Immunology, The 960th Hospital of the PLA Joint Logistics Support Force, Tai’an 271000, Shandong, China
    2. Department of Traditional Chinese Medicine, Taian City Central Hospital, Tai’an 271000, Shandong, China
  • Received:2021-08-16 Online:2021-12-18 Published:2021-12-13
  • Contact: Hui SONG E-mail:songhuitaszxyy@163.com

Abstract:

A 65-year-old woman developed erythema, papules and nodules over the body. Some nodules of her auricles and hands like string beads. Besides, she suffered from symmetrical swelling and pain of multiple joints, morning stiffness with deformity of joints; She had elevated erythrocyte sedimentation rate and C reactive protein levels; Her rheumatoid factor and antinuclear antibody were positive; Joints destruction was found with X-ray imaging; Skin pathology showed Dermal infiltrate of abundant histiocytes, part of them with a ground-glass appearance; A CD68 immunohistochemical stain was positive and the cells were negative for S100, CD1a. These findings were diagnostic evidences of multicentric reticulohistiocytosis (MRH). The patient received high-dose of glucocorticoids combinated with immunosuppressive agents, and achieved a satisfactory effect. MRH was a rare multisystem disease characterized by papulonodular mucocutaneous and destructive arthritis, and its pathogeny was not yet completely understood. The typical lesions of MRH were hard papules or nodules that usually occured on the hands, face and arms. Classic coral bead appearance from periungual cutaneous nodules that were characteristic of MRH. MRH was an inflammatory joint disease, affecting almost all the appendicular joints and characterized by joint multiple, symmetrical, destructive, progressive disability. Joints destruction of the distal interphalangeal joints was a unique feature of MRH. In addition to skin and joints, it could also involve other systems. There were no diagnostic laboratory markers for MRH. Laboratory examinations had often been found to be non-specific. Imageological examination mainly showed bone and joint destruction. Skin biopsy was the best test to diagnose MRH,the typical histopathological findings included an infiltrate with histiocytes and multinucleated giant cells with a ground-glass appearing in eosinophilic cytoplasm, and the immunohistochemical stain was positive for CD68. The diagnosis was typically made based on the clinical presentation, supportive radiographic findings and skin biopsy. MRH was easily possible to mistake for other more common autoimmune conditions, such as rheumatoid arthritis, psoriatic arthritis, osteoarthritis, and dermatomyositis, but the distinctive clinical, radiographic, and histologic features could aid in differentiating these diseases. MRH could mimic other rheumatic diseases, besides, it could also coexist with cancer or other autoimmune disorders. There was no standardized treatment for MRH. However, Nonsteroidal anti-inflammatory drugs,glucocorticoid, Immunosuppressant,biologic medications, and bisphosphonates had been used with varying degrees of curative effect. Treatment with glucocorticoid combined with immunosuppressants were effective for rash and arthritis, early use of them should be strongly considered,and refractory cases could be treated with biological agents. By reporting a MRH case and reviewing literature, this paper aims to help the clinicians improve the understanding of this rare disease, and suggests that when one diagnosis cannot explain the whole picture of the disease, and further evidence should be sought to confirm the diagnosis.

Key words: Multicentric reticulohistiocytosis, Diagnosis, Treatment

CLC Number: 

  • R59

Figure 1

Erythema and papules on face and neck"

Figure 2

String of beaded nodules on auricle"

Figure 3

Hand nodules and deformation of finger joints"

Figure 4

Radiographs of both hands showed joints destruction"

Figure 5

Skin pathology showed Dermal infiltrate of abundant histiocytes, part of them with a ground-glass appearance(HE ×400)"

Figure 6

Immunohistochemical staining CD68(+)"

Figure 7

Auricle nodules subsided after treatment"

Figure 8

Hand nodules eased after treatment"

[1] 王白鹤, 惠云, 苑春雨, 等. 多中心网状组织细胞增生症一例[J]. 中国麻风皮肤病杂志, 2018, 34(9):550-552.
[2] Luz FB, Gaspar TAP, Kalil-Gaspar N, et al. Multicentric reticulohistiocytosis[J]. J Eur Acad Dermatol Venereol, 2001, 15(6):524-531.
pmid: 11843211
[3] Tajirian AL, Malik MK, Robinson-Bostom L, et al. Multicentric reticulohistiocytosis[J]. Clin Dermatol, 2006, 24(6):486-492.
pmid: 17113966
[4] Tariq S, Hugenberg ST, Hirano-Ali SA, et al. Multicentric reticulohistiocytosis (MRH): Case report with review of literature between 1991 and 2014 with in depth analysis of various treatment regimens and outcomes[J]. Springerplus, 2016, 5(1):180.
doi: 10.1186/s40064-016-1874-5
[5] Sanchez-Alvarez C, Sandhu AS, Crowson CS, et al. Multicentric reticulohistiocytosis: The Mayo clinic experience (1980-2017)[J]. Rheumatology(Oxford), 2020, 59(8):1898-1905.
doi: 10.1093/rheumatology/kez555
[6] 李慧娟, 王立, 侯勇, 等. 多中心网状组织细胞增生症8例临床特征[J]. 中华临床免疫和变态反应杂志, 2015, 9(3):213-217.
[7] Lu YY, Lu CC, Wu CH. Leonine facies in the cutaneous form of multicentric reticulohistiocytosis[J]. Intern Med, 2012, 51(15):2069-2070.
doi: 10.2169/internalmedicine.51.8119
[8] Islam AD, Naguwa SM, Cheema GS, et al. Multicentric reticulohistiocytosis: A rare yet challenging disease[J]. Clin Rev Allergy Immunol, 2013, 45(2):281-289.
doi: 10.1007/s12016-013-8362-2
[9] Gorman JD, Danning C, Schumacher HR, et al. Multicentric reticulohistiocytosis: Case report with immunohistochemical analysis and literature review[J]. Arthritis Rheum, 2000, 43(4):930-938.
doi: 10.1002/1529-0131(200004)43:4<930::AID-ANR27>3.0.CO;2-A
[10] Yamamoto T. Skin manifestation associated with multicentric reticulohistiocytosis[J/OL]. J Clin Rheumatol, 2020(2020-12-15)[2021-08-01]. https://pubmed.ncbi.nlm.nih.gov/33337805/.
[11] El-Haddad B, Hammoud D, Shaver T, et al. Malignancy-associated multicentric reticulohistiocytosis[J]. Rheumatol Int, 2011, 31(9):1235-1238.
doi: 10.1007/s00296-009-1287-7 pmid: 20012625
[12] 白丽杰, 李鸿斌, 徐晓艳. 多中心网状组织细胞增多症1例并文献复习[J]. 临床荟萃, 2015, 30(7):831-832.
[13] Zhao H, Wu C, Wu M, et al. Tumor necrosis factor antagonists in the treatment of multicentric reticulohistiocytosis: Current clinical evidence[J]. Mol Med Rep, 2016, 14(1):209-217.
doi: 10.3892/mmr.2016.5253
[14] Lim K, D’Souza J, Vasquez JB, et al. Looks can be deceiving: A case report on multicentric reticulohistiocytosis successfully treated with rituximab[J]. Cureus, 2017, 9(5):e1220.
[15] Pacheco-Tena C, Reyes-Cordero G, Ochoa-Albíztegui R, et al. Treatment of multicentric reticulohistiocytosis with tocilizumab[J]. J Clin Rheumatol, 2013, 19(5):272-276.
doi: 10.1097/RHU.0b013e31829cf32b pmid: 23872542
[16] Aouba A, Leclerc-Mercier S, Fraitag S, et al. Assessment and effective targeting of Interleukin-1 in multicentric reticulohistyo-cytosis[J]. Joint Bone Spine, 2015, 82(4):280-283.
doi: 10.1016/j.jbspin.2015.02.003
[1] LI Yi,YU Hua-jie,QIU Li-xin. Clinical classification and treatment decision of implant fracture [J]. Journal of Peking University (Health Sciences), 2022, 54(1): 126-133.
[2] LI Wei-hao,LI Wei,ZHANG Xue-min,LI Qing-le,JIAO Yang,ZHANG Tao,JIANG Jing-jun,ZHANG Xiao-ming. Comparison of the outcomes between open and hybrid approaches in the treatment of thoracoabdominal aortic aneurysms repair [J]. Journal of Peking University (Health Sciences), 2022, 54(1): 177-181.
[3] MENG Guang-yan,ZHANG Yun-xiao,ZHANG Yu-xin,LIU Yan-ying. Clinical characteristics of central nervous system involvement in IgG4 related diseases [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1043-1048.
[4] WANG Fei,ZHU Xiang,HE Bei,ZHU Hong,SHEN Ning. Spontaneous remission of follicular bronchiolitis with nonspecific interstitial pneumonia: A case report and literature review [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1196-1200.
[5] Zheng-da ZHU,Yan GAO,Wen-xiu HE,Xin FANG,Yang LIU,Pan WEI,Zhi-min YAN,Hong HUA. Efficacy and safety of Nocardia rubra cell wall skeleton for the treatment of erosive oral lichen planus [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 964-969.
[6] Yan-fang JIANG,Jian WANG,Yong-jian WANG,Jia LIU,Yin PEI,Xiao-peng LIU,Ying-fang AO,Yong MA. Mid-to-long term clinical outcomes and predictors after anterior cruciate ligament revision [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 857-863.
[7] HONG Peng,TIAN Xiao-jun,ZHAO Xiao-yu,YANG Fei-long,LIU Zhuo,LU Min,ZHAO Lei,MA Lu-lin. Bilateral papillary renal cell carcinoma following kidney transplantation: A case report [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 811-813.
[8] YUAN Yuan,LANG Ning,YUAN Hui-shu. CT spectral curve in differentiating spinal tumor metastasis and infections [J]. Journal of Peking University (Health Sciences), 2021, 53(1): 183-187.
[9] Qi KANG,Ji-xin ZHANG,Ying GAO,Jun-qing ZHANG,Xiao-hui GUO. Analysis of diagnosis and treatment of 100 patients with Hürthle cell adenoma [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1098-1101.
[10] Gong CHENG,Xia ZHANG,Fei YANG,Jia-yu CHENG,Yan-ying LIU. Angioimmunoblastic T-cell lymphoma with fever, arthritis and skin pigmentation: A case report [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1150-1152.
[11] Cai-nan LUO,Zheng-fang LI,Li-jun WU,Hai-juan CHEN,Chun-mei YANG,Wen-hui XU,Xiao-ling LIU,Wei TANG,Ping QIAO,Baihetiya Rena. Multicenter performance of the different classification criteria for rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2020, 52(5): 897-901.
[12] Lu LIU,Jie TIAN,Kai WU,Ying GAO,Zheng ZHANG,Jun-qing ZHANG,Xiao-hui GUO. Clinical profile of pheochromocytoma and paraganglioma with normal plasma free metanephrines [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 614-620.
[13] Ren-tao TANG,Xin-hai LI,Jiang-li YU,Lin FENG,Xue-jun GAO. Evaluation of microtensile bond strength between resin composite and glass ceramic [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 755-761.
[14] Mei-lian CHEN,Yan GAO,Wei GUO,Li ZUO,Tian-bing WANG. Infection prevention and control of bedside blood purification treatment in patients with COVID-19 [J]. Journal of Peking University (Health Sciences), 2020, 52(3): 414-419.
[15] Wen-jun TANG,Hao-xiang TANG,Yi XING. Cannabis use among the drug users with compulsory detained detoxification treatment in China [J]. Journal of Peking University (Health Sciences), 2020, 52(3): 541-546.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Author. English Title Test[J]. Journal of Peking University(Health Sciences), 2010, 42(1): 1 -10 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 188 -191 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 376 -379 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 459 -462 .
[5] . [J]. Journal of Peking University(Health Sciences), 2010, 42(1): 82 -84 .
[6] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 319 -322 .
[7] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 333 -336 .
[8] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 337 -340 .
[9] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 225 -328 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 346 -350 .